know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Membership

Invest in Yourself

November 04, 2025

Renew your membership by Wednesday, December 31 to keep your exclusive resources, including access to our global network, top-ranked journals, and discounts to our annual meeting, ENDO. Elevate your career with premier, yearlong, professional development resources. We look forward to partnering with you in another year of growth, opportunity, and career advancement. Renew today!

Store

Meet the Professor 2025: Gain Expert Knowledge

November 05, 2025

This book and eBook presents forty-one cases encompassing medical vignettes, practice gaps, and key learning points. Each case includes expert analysis, diagnostic reasoning, and treatment strategies from leaders in endocrinology, diabetes, and metabolism. Strengthen your clinical skills and earn 30.0 AMA PRA Category 1 Credits™ and 30 ABIM MOC points. Order now

Store

Sharpen Your Skills with ESAP™ 2025

November 05, 2025

The latest edition of the Endocrine Self-Assessment Program (ESAP™) 2025 offers 120 new cases and the most up-to-date clinical guidelines. Earn up to 40 AMA PRA Category 1 Credits™ and 40 ABIM MOC points. Available in both print and eBook formats. Start learning today and strengthen your clinical expertise.

Awards

REGMS Applications Are Now Being Accepted

October 28, 2025

Gain hands-on experience in endocrine research through the Endocrine Society’s Research Experiences for Graduate and Medical Students (REGMS) program. Participants conduct a mentored summer project, join career-development webinars, and present their work during ENDO 2027. Awarded applicants receive a $2,500 honorarium and a $1,500 travel grant.

Advocacy

Advocacy in Action

November 07, 2025

Read our latest Advocacy in Action to learn about the White House's plan to expand coverage and lower prices of anti-obesity medications (AOM), as well as CMS's Final Medicare Physician Payment Rule for CY 2026, and more about the government shutdown.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Strong grip strength may protect against obesity-related complications

October 15, 2025

People with excess body fat who build and keep muscle may be less likely to develop obesity-induced heart, liver, or kidney damage or die early, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.

GLP-1s show promise in treating alcohol and drug addiction

October 09, 2025

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Society.

Endocrine Society honors endocrinology field’s leaders with 2026 Laureate Awards

September 10, 2025

The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field.

View More

Featured Journal Articles

Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency

November 04, 2025

The authors report a 63-year-old man with metastatic clear cell renal carcinoma treated with combined nivolumab and ipilimumab. After 3 cycles, he presented with severe headaches.

G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities

November 04, 2025

This review follows the timeline of discovery, highlighting current understanding of “old fashioned” signaling of G protein-coupled receptors and tyrosine kinase receptors and their relationships to “new world” immune receptors.

Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits

November 04, 2025

In this review, we propose a conceptual framework highlighting opportunities for future research and the therapeutic potential of targeting central glucagon-like peptide-1 pathways for obesity treatment.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.